Summary
Seasoned commercial executive with over 30 years of leadership in retinal disease across biotech and large pharma Brings established track record of successful product launches and oversight of prominent ophthalmology franchises, including Lucentis and
Source: GlobeNewswire
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
